Literature DB >> 26724861

FGF21 Regulates Sweet and Alcohol Preference.

Saswata Talukdar1, Bryn M Owen2, Parkyong Song2, Genaro Hernandez2, Yuan Zhang2, Yingjiang Zhou1, William T Scott2, Bhavna Paratala3, Tod Turner1, Andrew Smith3, Barbara Bernardo3, Christian P Müller4, Hao Tang5, David J Mangelsdorf6, Bryan Goodwin1, Steven A Kliewer7.   

Abstract

Fibroblast growth factor 21 (FGF21) is a hormone induced by various metabolic stresses, including ketogenic and high-carbohydrate diets, that regulates energy homeostasis. In humans, SNPs in and around the FGF21 gene have been associated with macronutrient preference, including carbohydrate, fat, and protein intake. Here we show that FGF21 administration markedly reduces sweet and alcohol preference in mice and sweet preference in cynomolgus monkeys. In mice, these effects require the FGF21 co-receptor β-Klotho in the central nervous system and correlate with reductions in dopamine concentrations in the nucleus accumbens. Since analogs of FGF21 are currently undergoing clinical evaluation for the treatment of obesity and type 2 diabetes, our findings raise the possibility that FGF21 administration could affect nutrient preference and other reward behaviors in humans.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26724861      PMCID: PMC4749404          DOI: 10.1016/j.cmet.2015.12.008

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  26 in total

Review 1.  The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement.

Authors:  Rueben A Gonzales; Martin O Job; William M Doyon
Journal:  Pharmacol Ther       Date:  2004-08       Impact factor: 12.310

2.  The tail suspension test.

Authors:  Adem Can; David T Dao; Chantelle E Terrillion; Sean C Piantadosi; Shambhu Bhat; Todd D Gould
Journal:  J Vis Exp       Date:  2012-01-28       Impact factor: 1.355

3.  FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.

Authors:  Qingning Liang; Ling Zhong; Jialiang Zhang; Yu Wang; Stefan R Bornstein; Chris R Triggle; Hong Ding; Karen S L Lam; Aimin Xu
Journal:  Diabetes       Date:  2014-07-14       Impact factor: 9.461

4.  Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice.

Authors:  Nicholas Douris; Darko M Stevanovic; Ffolliott M Fisher; Theodore I Cisu; Melissa J Chee; Ngoc L Nguyen; Eleen Zarebidaki; Andrew C Adams; Alexei Kharitonenkov; Jeffrey S Flier; Timothy J Bartness; Eleftheria Maratos-Flier
Journal:  Endocrinology       Date:  2015-04-29       Impact factor: 4.736

5.  Mechanistic investigation of the preclinical pharmacokinetics and interspecies scaling of PF-05231023, a fibroblast growth factor 21-antibody protein conjugate.

Authors:  Craig Giragossian; Chandra Vage; Jun Li; Kathleen Pelletier; Nicole Piché-Nicholas; Manoj Rajadhyaksha; Jennifer Liras; Alison Logan; Roberto A Calle; Yan Weng
Journal:  Drug Metab Dispos       Date:  2015-03-24       Impact factor: 3.922

6.  Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.

Authors:  David A Sarruf; Joshua P Thaler; Gregory J Morton; Jonathan German; Jonathan D Fischer; Kayoko Ogimoto; Michael W Schwartz
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

7.  Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.

Authors:  João Paulo G Camporez; François R Jornayvaz; Max C Petersen; Dominik Pesta; Blas A Guigni; Julie Serr; Dongyan Zhang; Mario Kahn; Varman T Samuel; Michael J Jurczak; Gerald I Shulman
Journal:  Endocrinology       Date:  2013-06-13       Impact factor: 4.736

8.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

9.  Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.

Authors:  Yan Weng; Jeffrey R Chabot; Barbara Bernardo; Qingyun Yan; Yimin Zhu; Martin B Brenner; Chandra Vage; Alison Logan; Roberto Calle; Saswata Talukdar
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

10.  FGF21 regulates metabolism and circadian behavior by acting on the nervous system.

Authors:  Angie L Bookout; Marleen H M de Groot; Bryn M Owen; Syann Lee; Laurent Gautron; Heather L Lawrence; Xunshan Ding; Joel K Elmquist; Joseph S Takahashi; David J Mangelsdorf; Steven A Kliewer
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

View more
  123 in total

Review 1.  Impact of Genes and Environment on Obesity and Cardiovascular Disease.

Authors:  Yoriko Heianza; Lu Qi
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

2.  Neuroendocrinology: FGF21 influences a 'sweet tooth' in mice.

Authors:  Tim Geach
Journal:  Nat Rev Endocrinol       Date:  2016-01-29       Impact factor: 43.330

Review 3.  What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium.

Authors:  Emily Qualls-Creekmore; Kara L Marlatt; Esther Aarts; Annadora Bruce-Keller; Tim S Church; Karine Clément; Jennifer O Fisher; Penny Gordon-Larsen; Christopher D Morrison; Helen E Raybould; Donna H Ryan; Philip R Schauer; Alan C Spector; Maartje S Spetter; Garret D Stuber; Hans-Rudolf Berthoud; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2020-06-10       Impact factor: 5.002

4.  Fibroblast Growth Factor-21 Controls Dietary Protein Intake in Male Mice.

Authors:  Karlton R Larson; Aki T-B Chaffin; Michael L Goodson; Yanbin Fang; Karen K Ryan
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 5.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

Review 6.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 7.  FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.

Authors:  Matthew J Potthoff
Journal:  Nat Rev Endocrinol       Date:  2016-12-16       Impact factor: 43.330

8.  Robust RBM3 and β-klotho expression in developing neurons in the human brain.

Authors:  Travis C Jackson; Keri Janesko-Feldman; Shaun W Carlson; Shawn E Kotermanski; Patrick M Kochanek
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-29       Impact factor: 6.200

Review 9.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

Review 10.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.